BOOSTING THE INNATE IMMUNE SYSTEM
Even with current vaccines, anti-virals and antibiotics
significant unmet needs remain to better prevent and treat respiratory infections
Pulmotect technology has demonstrated activity and completed Phase I clinical trials to address these unmet needs
Forecast sales for the immuno-stimulants market are estimated to reach $17.6 billion.
~ The Cancer Market Outlook:
Competitive landscape, pipeline analysis
and growth opportunities
More than 2 billion people worldwide
could be impacted by a pandemic. 160 million Americans will need to be vaccinated.
Despite remarkable advances in medical research and treatments during the 20th century, infectious diseases remain among the leading causes of death worldwide.
~ National Institute of
Allergy and Infectious Disease